Cancer 
        Digest        

A small clinical trial showed proof of concept of vaccine prevention of pancreatic cancer in high-risk individuals. (Image generated by WIX AI) CANCER DIGEST – July 19, 2026 – That’s the question asked by researchers led by Neeha Zaidi, MD, at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University. Approximately 10 percent of pancreatic cancers are associated with genetic predisposition caused by mutations in specific cancer susceptibility genes that are pa

A second PSMA-PET scan for both local and distant prostate cancer resulted in a change in treatment for nearly 50 percent of prostate cancer patients following initial treatment.

In a clinical trial, an experimental oral targeted medication nearly doubled overall survival in pancreatic cancer patients with a specific genetic mutation, compared to standard chemotherapy.

The complex interactions of hormone receptors often can result in treatment resistance for patients with HR+ and HER2+ advanced breast cancer. – Image credit Penn Medicine. CANCER DIGEST – June 27, 2026 – The U.S. Food and Drug Administration has approved the targeted drug palbociclib in combination with standard therapies for adult patients with hormone receptor-positive (HR+) and HER2-positive (HER2+) often called triple positive locally advanced or metastatic breast cancer

Women who used GLP-1 medications were about 30 percent less likely to develop breast cancer than similar women who did not use the drugs, according to a new retrospective study led by researchers at University of Pennsylvania

Scientists have discovered a new and previously undescribed virus that infects gut bacteria in patients with colorectal cancer.